Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial-Reference-Cited by-同舟云学术

Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial

Published:2019-09-20 Issue:6 Volume:13 Page:800-813
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Kumar Manoj^ORCID,Kainth Sumit,Choudhury Ashok,Maiwall Rakhi,Mitra Lalita G.,Saluja Vandana,Agarwal Prashant Mohan,Shasthry Saggere Muralikrishna,Jindal Ankur,Bhardwaj Ankit,Kumar Guresh,Sarin Shiv K.

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-019-09986-9.pdf

Reference34 articles.

1. Lebrec D, Nouel O, Bernuau J, Bouygues M, Rueff B, Benhamou JP. Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients. Lancet. 1981;1:920–1.

2. de Montmollin E, Aboab J, Mansart A, Annane D. Bench-to-bedside review: betaadrenergic modulation in sepsis. Crit Care. 2009;13:230.

3. Perez-Paramo M, Munoz J, Albillos A, Freile I, Portero F, Santos M, et al. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology. 2000;31:43–8.

4. Reiberger T, Ferlitsch A, Payer BA, Mandorfer M, Heinisch BB, Hayden H, et al. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol. 2013;58:911–21.

5. Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology. 2003;37:902–8.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating Cirrhosis: Presentation, Outcomes, and Treatments in Adulthood and Beyond;Current Treatment Options in Gastroenterology;2024-08-23

2. Effect of midodrine on HVPG in advanced chronic liver disease and acute‐on‐chronic liver failure—A pilot study;Liver International;2024-07-24

3. Non-Selective Beta-Blockers in Patients with Cirrhosis: Current Evidence and Controversy;Liver Cirrhosis and Its Complications - Advances in Diagnosis and Management;2024-06-17

4. APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure;Hepatology International;2024-04-05

5. Association of non-selective β blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis;Annals of Medicine;2024-01-25